1Q16 FINANCIAL RESULTS

Size: px
Start display at page:

Download "1Q16 FINANCIAL RESULTS"

Transcription

1 1Q16 FINANCIAL RESULTS Towards the execution of our plan Warsaw, 10 May 2016

2 Disclaimer This presentation (the Presentation ) has been prepared by Bank Polska Kasa Opieki Spółka Akcyjna ( Bank ) for the clients, shareholders and financial analysts. This presentation should not be treated as an offer or invitation to purchase any securities or financial instruments or as advice or recommendation in respect to such securities or financial instruments. The presented data are only general information and does not refer to an offer by the Bank for products or services. In order to take advantage of the services and products of the Bank, one should be thoroughly familiar with the characteristics of the particular service or product, its rules, risks and legal and tax consequences of the use of particular services or products. The strategy presented in this presentation contains goals which are the ambition of the Management Board and do not constitute any financial results forecast. Rights for the Presentation as a whole are reserved to the Bank. The Presentation is subject to the protection provided by law, in particular: the Act dated 4 February 1994 on Copyright and Related Rights (consolidated text in Journal. Laws of 2006, No. 90, item. 631, as amended); the Act dated 27 July 2001 on the protection of Databases (Journal of Laws No. 128, item. 1402, as amended); the Act dated 16 April 1993 on Combating Unfair Competition (consolidated text in Journal of Laws of 2003, No. 153, item 1503, as amended) and the Act dated 30 June 2000 on Industrial Property Law (consolidated text in Journal. Laws of 2003, No. 119, item. 1117, as amended). This presentation may include forward looking statements, the Bank s outlook for the future, future plans and strategies or anticipated events that are not historical facts. Since these statements are based on assumptions, expectations, projections and provisional data about future events, the content is inherently uncertain. Factors that could cause or contribute to differences in current expectations include, but are not limited to: (i) general economic conditions, among which the economic conditions of the business areas and the markets in which the Bank and its subsidiaries operate, (ii) the performance of financial markets (iii) changes in laws or regulations and (iv) general competitive conditions locally, regionally, nationally and/or internationally. The Bank does not undertake to publish any updates, modifications or revisions of the information, data or statements contained herein should there be any change in the strategy or intentions of the Bank, or should facts or events occur that affect the Bank s strategy or intentions, unless such reporting obligations arise under applicable laws and regulations. Neither the Bank, nor any of its representatives shall be responsible for any loss or damage that may arise from the use of this Presentation or of any information contained herein or otherwise arising in connection to this Presentation. This presentation is not for distribution in or into countries where the public dissemination of the information contained herein may be restricted or prohibited by law. 1

3 1Q16 highlights Net profit of PLN 573mn (PLN 654mn excluding banking tax, +4.7% yoy). PLN 1bn gross operating profit, at the highest quarterly performance of NIM improving q/q supported by optimization of assets mix. Sound yoy growth of retail volumes, both key loans and deposits. Strong cost and risk control. 2

4 Net profit and gross operating profit Net profit (PLN mn) Gross operating profit (PLN mn) +4.7% -0.1% % 573 1Q15 1Q16 1Q15 1Q16 Impact of new banking tax PLN 654mn in net profit excluding banking tax, +4.7% yoy. Gross operating profit exceeds PLN 1bn. 3 - dynamic excluding impact of new banking tax

5 Operating income PLN mn +0.5% Q15 1Q16 Net interest income F&C Other income PLN 1 817mn in operating income, +0.5% yoy, as growth in NII offsets the impact of weaker capital markets; other income at previous year s level. 4

6 Net interest income and net interest margin Net interest income (PLN mn) Net interest margin +2.6% ,88% 2,76% 2,73% 2,73% 2,75% 1Q15 1Q16 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16 NII at PLN 1 070mn, +2.6% yoy, supported by growth in customer volumes. NIM improved to 2.75% on positive developments in both the asset mix and liabilities pricing. 5

7 Loans Retail loans (PLN mn) Corporate loans (PLN mn) +11.4% +8.1% +1.8% -1.1% Mar 15 Dec 15 Mar 16 Mar 15 Dec 15 Mar 16 Key retail loans Other retail loans Key corporate loans Other corporate loans * Solid growth in key retail lending +11.4% yoy. Key corporate lending +8.1% yoy. 6 * Other corporate loans without BSB and reverse repo transactions: 6.3 bn 1Q15; 4.8 bn 4Q15; 0.1 bn 1Q16

8 New key retail lending Consumer loans volume sale - avg. daily (PLN mn) New loans volume (PLN mn) +30.2% 2.8 bn in 1 quarter 20,9 27, Q 16 Apr 16 PLN mortgage loans volume sale - avg. daily (PLN mn) ,2 +9.0% 26,4 Jan 16 Feb Mar Apr Consumer loans PLN mortgage loans 1Q 16 Apr 16 PLN 2.8bn in new loans in the first quarter, acceleration in April. 7

9 Savings Retail savings (PLN mn) Corporate deposits* (PLN mn) +14.1% -9.8% +3.2% -9.2% Mar 15 Dec 15 Mar 16 Mar 15 Dec 15 Mar 16 Retail deposits MF Double-digit growth in retail deposits +14.1% yoy, supported by strong quarterly performance +3.2% qoq. Corporate deposits dynamic reflecting focus on margins, while preserving safe liquidity level. 8 * Corporate deposits presented without SBB and repo transactions: 4.1bn 1Q15; 4.5 bn 4Q15; 0.7 bn 1Q16

10 Net fees and commissions PLN mn -0.2% Q15 1Q % Other Lending Cards Capital Markets Banking fees and commissions flat yoy, capital markets down 16.6% affected by industrywide pressure. 9

11 Operating costs and other charges PLN mn +1.3% Cost Q 15 1Q 16 BGF + banking tax Cost incl. BGF, banking tax Personnel costs Non-personel costs Depreciation PLN 812mn in operating costs, +1.3% yoy, C/I at 44.7%. Regulatory charges at 148mn. 10

12 Assets quality Loans (PLN mn) 7.2% % 6.5% Cost of risk Mar 15 Dec 15 Mar 16 NPL Performing NPL ratio 0.61% 0.53% 0.44% 0.47% Provision coverage ratio 1Q15 4Q15 1Q % 73.3% 73.8% Mar 15 Dec 15 Mar 16 Cost of risk at 47bp. NPL ratio at 6.5%, coverage ratio at 73.8%. 11 Note: Performing loans without BSB and reverse repo transactions

13 Conclusions PLN 573mn in net profit, firmly on the path to fulfillment of the 2016 plan. Sound growth of retail volumes, both loans and deposits. Continuation of improvements in assets-liabilities mix supporting NIM. Good quarterly profit and visible commercial acceleration underscore our confidence in reiterating our 2016 ambition. 12

14 AGENDA Appendix 13

15 Polish economy outlook F GDP, % y/y Consumption, % y/y Investments, % y/y Unemployment, % eop CPI, % avg M Wibor, % avg Reference rate, % eop Exchange rate EUR, eop Exchange rate USD, eop Public sector balance, % GDP Note: Internal macroeconomic scenario 14

16 Polish banking sector outlook F 2016F (2) Loans, % y/y ,6 Retail, % y/y ,2 Mortgage loans PLN ,0 Consumer loans (1) ,8 Corporate, % y/y ,2 SME loans 6.3 7,0 4,0 Savings (3),% y/y ,4 Deposits, % y/y ,3 Retail, % y/y ,3 Corporate, % y/y ,8 Mutual Funds (4),% y/y (1) all non-mortgage retail loans (2) Internal scenario (3) deposits + assets in mutual funds dedicated to retail cliens (4) assets in mutual funds dedicated to retail clients

17 16 Polish economy trends Key parameters (1) GDP (% YoY) FIXED INVESTMENTS (% YoY) 1,9 1,5 7,7 7,3 6,9 6,9 8 3,7 5,5 4,9 1,9 2,7 2,1 4,2 3,6 4 4,8 4,8 4,9 0,9 0,1 5 2,3 3,3 0 0,5 5,3 6 1,8 2,6 3,3 3,3 3,3 3,3 3,6 3,1 3,4 4,3 3 5,4 7,8 10,4 9,6 4 5,0 5,3 6,7 2-0,7-4,7-2,9 24,0 22,6 0,7 0,1 2,5-0,1-3,2-4,9-2,5-3,5-0,2 0,3 12,0 9,6 9,79,711,8-2,5 5,8 4,4 4,4 0-9,3 19,2 15,9 13,014,5 0, Q 07 2Q 07 3Q 07 4Q 07 1Q 08 2Q 08 3Q 08 4Q 08 1Q 09 2Q 09 3Q 09 4Q 09 1Q 10 2Q 10 3Q 10 4Q10 1Q11 2Q 11 3Q 11 4Q 11 1Q 12 2Q 12 3Q 12 4Q 12 1Q13 2Q13 3Q 13 4Q 13 1Q 14 2Q 14 3Q 14 4Q 14 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16F 1Q 07 2Q 07 3Q 07 4Q 07 1Q 08 2Q 08 3Q 08 4Q 08 1Q 09 2Q 09 3Q 09 4Q 09 1Q 10 2Q 10 3Q 10 4Q 10 1Q 11 2Q 11 3Q 11 4Q 11 1Q 12 2Q 12 3Q 12 4Q 12 1Q 13 2Q 13 3Q 13 4Q 13 1Q 14 2Q 14 3Q 14 4Q 14 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16F GDP Pr Consumption contribution Net export contribution Investment contribution TRADE BALANCE ACCOUNT (bln EUR) PRIVATE CONSUMPTION (% YoY) 8,2 6,3 5,9 4, ,4 2,6 3,6 3,2 6 5,8 1,7 2,7 2,6 3,1 3,7 3,6 0,8 2,4 2,1 0,2 0 0,2 3,3-0,5 0,7 0,7 2,3 2,9 2,32,8 3,13,1 3, ,3-4,1-3,8-5,2-5,9-4,6-6,5-1,6-2,1-2,3-2,0-3,1-3,5-2,5-4,1-3,3-3,4-2,8-2,2-1,2 0,5-1,9-1,1 0,3-0,1-0,8-0,4-1,2 0,2-0,9 1,7 1, 1,3 1Q 07 2Q 07 3Q 07 4Q 07 1Q 08 2Q 08 3Q 08 4Q 08 1Q 09 2Q 09 3Q 09 4Q 09 1Q 10 2Q 10 3Q 10 4Q10 1Q11 2Q 11 3Q 11 4Q 11 1Q 12 2Q 12 3Q 12 4Q 12 1Q 13 2Q 13 3Q 13 4Q 13 1Q 14 2Q 14 3Q 14 4Q 14 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16F 1Q 07 2Q 07 3Q 07 4Q 07 1Q 08 2Q 08 3Q 08 4Q 08 1Q 09 2Q 09 3Q 09 4Q 09 1Q 10 2Q 10 3Q 10 4Q 10 1Q 11 2Q 11 3Q 11 4Q 11 1Q 12 2Q 12 3Q 12 4Q 12 1Q 13 2Q 13 3Q 13 4Q 13 1Q 14 2Q 14 3Q 14 4Q 14 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16F Source: Central Statistical Office; March 2007 March 2016

18 17 Polish economy trends Key parameters (2) CORPORATE EMPLOYMENT (ths. eop) ,8 5,0 5, ,2 4,5 4,7 4, , ,9 2, ,6 1, , Q 06 2Q 07 4Q 07 2Q 08 4Q 08 2Q 09 4Q 09 2Q 10 4Q10F ,7-2,3-2,1-1,0 UNEMPLOYMENT (%) AVERAGE CORPORATE WAGES (% YoY) 5,4 7,8 8,99,8 11,8 10,1 12,0 7,8 6,3 3,5 3,43,6 11,0 2,7 3,8 3,3 4,3 4,35,25,3 3,8 5,4 4,6 2,3 2,6 2,0 2,23,03,0 4,1 4,1 3,5 3,43,9 3,1 3,63,43,7 RETAIL SALES (real terms, % YoY) 1Q 07 2Q 07 3Q 07 4Q 07 1Q 08 2Q 08 3Q 08 4Q 08 1Q 09 2Q 09 3Q 09 4Q 09 1Q 10 2Q 10 3Q 10 4Q10 1Q 11 2Q 11 3Q 11 4Q 11 1Q 12 2Q 12 3Q 12 4Q 12 1Q 13 2Q 13 3Q 13 4Q 13 1Q 14 2Q 14 3Q 14 4Q 14 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16 4Q 06 1Q 07 2Q 07 3Q 07 4Q 07 1Q 08 2Q 08 3Q 08 4Q 08 1Q 09 2Q 09 3Q 09 4Q 09 1Q 10 2Q 10 3Q 10 4Q10 1Q 11 2Q 11 3Q 11 4Q 11 1Q 12 2Q 12 3Q 12 4Q 12 1Q 13 2Q 13 3Q 13 4Q 13 1Q 14 2Q 14 3Q 14 4Q 14 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16 Avg. Corporate Wages CPI 17,4 14,0 12,8 16,1 12,1 11,8 4,8 1,0 1,0 8,4 3,6 4,7 0,3 1,1 2,9 7,3 6,0 8,8 7,1 6,98,4 2,7 1,9-2,00,01,5 3,9 4,2 5,5 5,1 2,6 3,74,2 3,5 2,8 4,8 4,4 1Q 07 2Q 07 3Q 07 4Q 07 1Q 08 2Q 08 3Q 08 4Q 08 1Q 09 2Q 09 3Q 09 4Q 09 1Q 10 2Q 10 3Q 10 4Q10 1Q 11 2Q 11 3Q 11 4Q 11 1Q 12 2Q 12 3Q 12 4Q 12 1Q 13 2Q 13 3Q 13 4Q 13 1Q 14 2Q 14 3Q 14 4Q 14 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16 9,4 8,9 12,3 11,6 11,2 10,9 9,5 14,3 11,1 10,610,9 12,1 11,7 11,5 13,0 12,4 11,9 11,8 13,3 12,5 13,3 13,4 12,3 12,4 11,5 14,3 13,2 13,013,4 13,5 12,0 11,4 11,5 10,2 9,7 9,810 1Q 07 2Q 07 3Q 07 4Q 07 1Q 08 2Q 08 3Q 08 4Q 08 1Q 09 2Q 09 3Q 09 4Q 09 1Q 10 2Q 10 3Q 10 4Q10 1Q 11 2Q 11 3Q 11 4Q 11 1Q 12 2Q 12 3Q 12 4Q 12 1Q 13 2Q 13 3Q 13 4Q 13 1Q 14 2Q 14 3Q 14 4Q 14 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16 Source: Central Statistical Office; March 2007 March 2016

19 18 Polish economy trends Key parameters (3) EXCHANGE RATES INFLATION, INTEREST RATES 1Q 07 2Q 07 3Q 07 4Q 07 1Q 08 2Q 08 3Q 08 4Q 08 1Q 09 2Q 09 3Q 09 4Q 09 1Q 10 2Q 10 3Q 10 4Q10 1Q 11 2Q 11 2,2 2,0 2,0 2,4 3,7 3,0 2,2 3,8 3,3 3,6 2,9 3,5 4,7 4,0 4,3 3,2 3,5 3,7 3,5 3,5 3,5 3,5 3,5 3,5 3,8 4,1 5,0 4,2 4,2 4,5 4,8 5,0 5,8 6,0 6,0 4,4 4,2 4,3 4,1 3,9 3,8 4,0 4,2 4,7 5,9 5,1 5,7 6,2 6,7 6,6 3Q 11 4,5 4,6 4,7 4Q 11 1Q 12 2Q 12 3Q 12 4Q 12 1Q 13 2Q 13 3Q 13 4Q 13 0,5 1,3 1,1 2,9 2,8 2,5 3,3 3,9 4,0 4,3 4,1 4,1 2,7 2,7 2,7 3,4 4,5 4,5 4,6 4,5 4,8 4,8 4,1 4,9 4,8 5,0 4,9 5,1 1Q 14 2Q 14 3Q 14 4Q 14 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16-0,3-0,7-1,5-0,9-0,7-0,5-0,9 0,3 0,6 0,7 1,5 2,0 1,5 1,5 1,5 1,5 2,5 2,5 2,5 2,5 1,73 1,72 1,67 1,72 2,3 2,1 1,9 2,7 2,7 Source: NBP CPI REF. RATE 3M WIBOR

20 19 Banking sector trends Key parameters - yoy (4) HOUSEHOLDS AND CORPORATE LENDING (% YoY) HOUSEHOLDS AND CORPORATE DEPOSITS (% YoY) Households Corporate Corporate Households Q 02 4Q 03 4Q 04 4Q 05 4Q 06 4Q 07 4Q 08 4Q 09 4Q 10 4Q 11 1Q 12 2Q 12 3Q 12 4Q 12 1Q 13 2Q 13 3Q 13 4Q 13 1Q 14 2Q 14 3Q 14 4Q 14 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16 TOTAL SECTOR LENDING (% YoY) TOTAL SECTOR DEPOSITS (% YoY) Q 02 4Q 03 4Q 04 4Q 05 4Q 06 4Q 07 4Q 08 4Q 09 4Q 10 4Q 11 1Q 12 2Q 12 3Q 12 4Q 12 1Q 13 2Q 13 3Q 13 4Q 13 1Q 14 2Q 14 3Q 14 4Q 14 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16 4Q 02 4Q 03 4Q 04 4Q 05 4Q 06 4Q 07 4Q 08 4Q 09 4Q 10 4Q 11 1Q 12 2Q 12 3Q 12 4Q 12 1Q 13 2Q 13 3Q 13 4Q 13 1Q 14 2Q 14 3Q 14 4Q 14 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16 4Q 02 4Q 03 4Q 04 4Q 05 4Q 06 4Q 07 4Q 08 4Q 09 4Q 10 4Q 11 1Q 12 2Q 12 3Q 12 4Q 12 1Q 13 2Q 13 3Q 13 4Q 13 1Q 14 2Q 14 3Q 14 4Q 14 1Q 15 2Q 15 3Q 15 4Q 15 1Q 16 Source: NBP; December 2002 March 2016

21 Banking sector trends Key parameters - YTD (5) HOUSEHOLDS LENDING (% YTD) HOUSEHOLDS DEPOSITS (% YTD) 50% 45% 40% 35% % 30% 25% % 25% 20% 15% 20% 15% 10% 10% 5% 0% 5% 0% -5% XII' I II III IV V VI VII VIII IX X XI XII -5% XII' I II III IV V VI VII VIII IX X XI XII CORPORATE LENDING (% YTD) CORPORATE DEPOSITS (% YTD) 35% 30% 25% 20% % 12% 7% % 2% 10% 5% 0% -3% -8% -5% I II III IV V VI VII VIII IX X XI XII -13% XII' I II III IV V VI VII VIII IX X XI XII Source: NBP; January 2007 December

22 9,3% 8,8% 8,2% 7,6% 12,7% 7,4% 12,4% 12,5% 11,5% 11,3% 3,2% 3,2% 3,1% 3,4% 14,4% 14,2% 3,4% 3,3% 13,9% 12,8% 13,0% 2,9% 2,9% 12,3% 12,2% 12,3% 12,4% 13,4% 12,6% 12,2% 13,2% 12,3% 13,1% 12,7% 12,3% 12,7% 8,7% 7,7% 7,6% 9,7% 9,8% 9,1% 9,4% 8,4% 9,0% 9,7% 11,2% 12,4% 14,1% 9,6% 7,5% 9,9% 6,6% Mar 09 Sep 09 Mar 10 Sep 10 Mar 11 Sep 11 Mar 12 Sep 12 Mar 13 Sep 13 Mar 14 Sep 14 Dec 14 Mar 15 Jun 15 Sep 15 Dec 15 Feb 16 17,2% 18,0% 17,8% 18,2% 17,8% 18,2% 17,8% 17,9% 17,3% 17,3% 16,1% 15,6% 14,7% 9,1% 10,0%11,3%13,1%14,8%15,8%16,9% 1,8% 1,9% 2,0% 2,1% 2,2% 2,3% 2,5% 2,6% 2,7% 2,8% 2,9% 3,0% 3,0% 3,1% 3,1% 21 Banking sector trends Non-performing loans (6) HOUSEHOLDS NPL RATIO CORPORATE NPL RATIO Source: NBP SME Corporate 1,2% 1,3% 1,4% 1,5% 1,5% 1,6% Mar 09 Sep 09 Mar 10 Sep 10 Mar 11 Sep 11 Mar 12 Sep 12 Mar 13 Sep 13 Mar 14 Sep 14 Mar 15 Sep 15 Feb 16 Mortgage Cash 4,5% 4,9% 6,0%6,6% 6,7%7,2% 7,2% 7,4% 7,2% 7,3% 7,2% 7,5% 7,3% 7,5% 7,4% 7,5% 7,2% 7,1% 7,1% 7,0% 7,0% 6,9% 6,5% 6,8% 6,6% 6,5% 6,2% 6,3% Mar 09 Jun 09 Dec 09 Mar 10 Jun 10 Sep 10 Dec 10 Mar 11 Jun 11 Sep 11 Dec 11 Mar 12 Jun 12 Sep 12 Dec 12 Mar 13 Jun 13 Sep 13 Dec 13 Mar 14 Jun 14 Sep 14 Dec 14 Mar 15 Jun 15 Sep 15 Dec 15 Feb 15 Total retail 8,4% 10,1% 9,6% 11,5% 11,2%12,2% 12,2% 12,4% 11,5% 10,9% 10,7% 10,5% 10,4% 11,1% 11,3% 11,7% 11,8% 11,8% 11,5% 11,5% 11,4% 10,7% 11,2% 11,3% 10,9% 10,6% 9,8% 9,6% Mar 09 Jun 09 Sep 09 Dec 09 Mar 10 Jun 10 Sep 10 Dec 10 Mar 11 Jun 11 Sep 11 Dec 11 Mar 12 Jun 12 Sep 12 Dec 12 Mar 13 Jun 13 Sep 13 Dec 13 Mar 14 Jun 14 Sep 14 Dec 14 Mar 15 Jun 15 Sep 15 Dec 15 Feb 16 Total corporate

23 22 Selected data

24 Consolidated income statement mln PLN 1Q 15 4Q 15 1Q 16 Q/Q% Y/Y% Net interest income (1) ,8% 2,0% Net fee and commission ,1% -3,6% Operating income ,8% 0,5% Operating costs (2) ,7% 1,3% OPERATING PROFIT ,7% -0,1% Provisions ,6% -5,6% Guarantee funds charges ,2% -2,9% Banking tax #DZIEL/0! #DZIEL/0! Extraordinary contribution to BGF (SK Bank) and Borrowers Support Fund PROFIT BEFORE INCOME TAX ,8% -6,0% Income tax ,2% 2,9% GROUP NET INCOME (3) ,8% -8,2% Cost/Income Ratio (%) (4) 44,3% 45,2% 44,7% - 0,5 0,4 Cost of Risk (%) 0,53% 0,44% 0,47% 0,0-0,1 ROE (%) 10,3% 7,6% 9,7% 2,1-0,6 ROE normalised (%) (5) 15,1% 11,5% 14,9% 3,4-0,2 ROA (%) 1,5% --- 1,4% #ARG! - 0,1 TCR (%) - Basel 3 17,6% 17,7% 18,4% 0,7 0,8 NIM (%) (6) 2,88% 2,73% 2,75% 0,0-0,1 L/D (%) (7) 91,7% 92,1% 94,9% 2,8 3,2 23 (1) NII and dividends and other income from equity investments (3) Net profit attributable to equity holders of the Bank (5) ROE assuming TCR at 10% (6) NIM calculated based on average daily working assets (2) Costs excl. guarantee funds charges (4) Operating cost excluding guarantee funds charges (7) Loans excluding repo and buy-sell-back transactions, deposits includes only clients liabilities and debt issue excluding reverse repo transactions and sell buy-back

25 Activity by segments mln PLN Retail Banking Private Banking Corporate&Investment Banking Assets&Liabilities Management & Others Group 3M 15 3M 16 Y/Y % 3M 15 3M 16 Y/Y % 3M 15 3M 16 Y/Y % 3M 15 3M 16 Y/Y % 3M 15 3M 16 Y/Y % Net interest income (1) % % % % % Non-interest income % % % % % Operating income % % % % % Operating costs (2) % % % 1,2-0,5-139% % OPERATING PROFIT % % % % % Net write-downs/provision % % % % % Guarantee funds charges % % % % Banking tax PROFIT BEFORE INCOME TAX % 0,3 3,0 762% % % ,0% (1) Total net interest income, dividends and other income from equity investments 24 (2) Operating cost excluding guarantee funds charges

26 The structure of the Group net profit mln PLN cumulative Group's share in capital % 3M 15 3M 16 Y/Y % Bank Pekao S.A. Banking - Poland 723,5 603,0-16,7% Entities - consolidated under full method 85,2 23,0-73% of which: (*) Pekao Leasing Sp. z o.o. Leasing 36% 9,2 9,5 3% Centralny Dom Maklerski Pekao S.A. Brokerage 100% 10,4 5,3-49% Pekao Bank Hipoteczny S.A. Mortgage Bank 100% 0,1 2,0 1900% Pekao Pioneer PTE S.A. Pension Fund 65% 0,4 0,2-50% Pekao Faktoring Sp. z o.o. Factoring 100% 1,7 1,7 0% Pekao Investment Banking S.A. Brokerage 100% 1,0 1,5 Centrum Bankowości Bezpośredniej Sp. z o.o. Call Centre 100% 0,3 0,2-33% Pekao Financial Services Sp. z o.o. Servicing MF/PF 100% 2,0 2,2 10% Centrum Kart S.A. Cards 100% -0,9 0,0-100% Pekao Fundusz Kapitałowy Sp. z o.o. Business consulting 100% 0,1 0,1 0% Pekao Property S.A. Real estate development 100% 0,0-0,1 Entities - valued under the equity method 15,5 10,0-35% Pioneer Pekao Investment Management S.A. Mutual Funds 49% 11,8 9,6-19% Krajowa Izba Rozliczeniowa S.A. Clearing Services 5,70% 3,3 --- #ARG! Dom Inwestycyjny Xelion Sp. z o.o. Financial Advisory 50% 0,4 0,4 0% Exclusions and consolidation adjustments -199,8-62,6-69% Group Net Profit (**) 624,4 573,4-8,2% 25 (*) Entities in liquidation, sold or indirect ownership not presented (**) Group net profit attributable to equity holders of the Bank (reported) NOTE: Data as reported

27 Consolidated income statement F&C breakdown mln PLN 1Q 15 4Q 15 1Q 16 Q/Q% Y/Y% Lending incl. DCM ,8% 0,0% Cards ,9% 10,7% Mutual Funds ,6% -22,8% Brokerage ,8% 7,0% Payments ,1% 0,3% Other ,6% -6,9% Net fee and commission ,1% -3,6% Other excl DCM incl brokerage and payments ,7% -3,5% 26

28 Consolidated income statement Cost breakdown mln PLN 1Q 15 4Q 15 1Q 16 Q/Q% Y/Y% Payroll costs ,1% -0,2% Other administrative expenses (1) ,5% 3,0% Depreciation ,2% 5,0% Operating costs (1) ,7% 1,3% Guarantee funds charges (BGF) ,2% -2,9% Operating costs +BGF ,4% 1,0% Extraordinary contribution to BGF (SK Bank) and Borrowers Support Fund Operating costs + BGF+ other contributions ,0% 1,0% (1) Operating cost excluding guarantee funds charges 27

29 Consolidated balance sheet mln PLN Mar 15 Dec 15 Mar 16 Q/Q % Y/Y % Cash and amounts due from Central Bank % -12% Loans and advances to banks % -53% Loans and advances to customers* % 0% Investment securities % 23% Assets held for sale % 23% Intangible assets % -6% Tangible fixed assets % -6% TOTAL ASSETS ,4% -2,3% Amounts due to the Central Bank % 567% Amounts due to other banks % 12% Financial liabilities held for trading % 62% Amounts due to customers % 0% Debt securities issued % -44% Total liabilities ,7% -2,4% Total Shareholders' equity ,7% -1,9% (*) Including loans and advances from customers and receivables from finance leases 28

30 Customers financing mln PLN Mar 15 Dec 15 Mar 16 Q/Q % Y/Y % Loans* ,4% 3,9% retail % 8% corporate % 0% Non quoted securities ,4% 11,0% Other % 42% Nominal value adjustment % 104% Impairment losses % 0% Net loans and advances % 0% Securities issues by non monetary entities** Reverse repo and buy-sell-back transactions ,6% -5,8% ,8% -99,1% TOTAL CUSTOMERS FINANCING*** % -1% (*) Including debt securities eligible for rediscounting at Central Bank, net investments in financial leases to customers 29 (**) Securities issued by non monetary entities including local governments (***) Total customers financing includes Loans and advances at nominal value, Securities issued by non monetary entities, reverse repo transactions and buy-sell-back

31 Selected data Bank Mar 15 Dec 15 Mar 16 Q/Q % Y/Y % Outlets ,6% -6,2% ATM's ,5% -3,6% Employees ,1% -2,3% No of PLN current accounts (ths)* ,4% 2,2% No of mortgage loan accounts (ths)** ,4% 7,3% No of clients holding a consumer loan accounts (ths)*** ,6% -1,8% Number of individuals with an access to electronic banking Pekao24 (ths) ,9% 8,4% Number of individuals with an access to mobile banking (ths) ,1% 70,0% Number of business clients (SME) with an access to electronic banking systems (ths) ,8% 2,9% Group Mar 15 Dec 15 Mar 16 Q/Q % Y/Y % Employees**** ,1% -2,3% Outlets**** ,6% -6,2% ATM's**** ,5% -3,6% Number of MF accounts (ths)***** ,7% -8,6% Number of Brokerage accounts (ths)****** ,0% -1,5% (*) Number of accounts including pre-paid card accounts 30 (**) Retail clients accounts (***) Pożyczka Ekspresowa (Express Loan) (****) Credit Union (SKOK) Kopernik included since Dec 2014 (****) Pioneer Pekao Investment Management S.A. (*****) Including: Dom Maklerski Pekao (Dom Maklerski), subsidiarycentralny Dom Maklerski Pekao S.A. (CDM), and associated entity Dom Inwestycyjny Xelion Sp. z o.o. (Xelion)

32 Loans exposure - sectors SECTOR DESCRIPTION* Wholesale and retail trade; repair of motor vehicles and motorcycles 12,9% 14,2% 15,2% Public administration and defence; compulsory social security 13,0% 11,9% 10,9% Real estate activities 12,6% 10,4% 10,5% Electricity, gas, steam and air conditioning supply 8,8% 9,0% 8,6% Finanace and Insurance activity 5,9% 9,6% 7,8% Transportation and storage 6,3% 6,8% 7,2% Construction 5,8% 5,1% 6,3% Mining and quarrying 3,0% 3,9% 4,4% Manufacture of metals, metal products and machinery 3,8% 3,8% 4,0% Manufacture of beverages and food products 3,4% 3,1% 3,8% Manufacture of chemicals, pharmaceuticals and refined petroleum products 3,8% 2,8% 2,9% Information and communication 4,3% 5,0% 2,7% Manufacture of rubber, plastic and non-metalic products 2,3% 1,9% 2,1% Other manufacturing 5,4% 4,5% 5,2% Other sectors 8,7% 8,0% 8,4% Total 100% 100% 100% Note: Based on the annual Group data including current exposure and commitment 31

33 Mutual funds Mutual funds volumes (mln PLN ) -7.2% -2.2% Mutual funds - assets structure (PPIM SA) % 14% Third party funds distributed by the Group PPIM SA Mar 15 Dec 15 Mar 16 69% Market share (%) 18,4% 17,9% 17,4% Eguity funds Balance funds Money and bonds funds Mar 15 Dec 15 Mar 16 Note: Market share funds distributed by Pekao Group, compared with the market of retail investment funds available for individuals 32

34 Key lending products Stock PLN mortgage loans volumes (mln PLN) Consumer loans volumes (mln PLN) +11.8% +9.8% +2.0% +0.7% Mar 15 Jun 15 Sep 15 Dec 15 Mar 16 Mar 15 Jun 15 Sep 15 Dec 15 Mar 16 33

35 Ratings of Bank Pekao S.A. FITCH RATINGS PEKAO*** POLAND Long-term rating (IDR) A- A- Short-term rating F2 F2 Viability rating a- Support rating 2 Outlook Stable Stable STANDARD AND POOR'S PEKAO POLAND Long-term rating BBB+ BBB+ Short-term rating A-2 A-2 Stand-alone bbb+ Outlook Negative* Negative* MOODY'S INVESTORS SERVICE LTD PEKAO (unsolicited rating) POLAND Long-term foreign-currency deposit rating A2 A2 Short-term deposit rating Prime-1 Prime-1 BCA baa1 Outlook Stable Stable/ Negative** 34 NOTES: Bank Pekao S.A. s Viability rating at a- from Fitch Ratings, Stand-alone one at bbb+ from S&P and BCA at baa1 from Moody s are the highest individual ratings assigned by (**) these rating agencies to banks rated in Poland Stable for the economy and Negative for the banking sector in Poland (*) On January 15, Standard and Poor's Ratings Services ("Standard & Poor's") downgraded the ratings Poland to the following levels:(1) LTR in foreign currency from A- to BBB+ (2) STR in national currency - accordingly to A- and A-2 (3) Outlook for both the local and foreign currency ratings changed to Negative. On January 19, 2016 Rating agency reviewed and confirmed the ratings of Bank at unchanged levels. The negative outlook indicates rating agency view of the one-in-three probability of EU BRRD Directive implementation in Poland that could lead to an increased bail-in risk. (***) On April 1, 2016 agency Fitch Ratings confirmed the ratings of Bank at unchanged levels

36 Investor relations team s contact and calendar CONTACT DETAILS Q&A related to the presentation: Dariusz Choryło Executive Director ph.: dariusz.chorylo@pekao.com.pl Wioletta Reimer Director of IR Office ph.: wioletta.reimer@pekao.com.pl 9 February April May July August 2016 FINANCIAL CALENDAR Annual Report 2015 and Webcasting Start of Blackout Period First Quarter Report and Webcasting Start of Blackout Period Semi-annual Report and Webcasting Dorota Faszczewska-Ward ph.: dorota.faszczewska-ward@pekao.com.pl Iwona Milewska ph.: iwona.milewska@pekao.com.pl Krzysztof Szlichciński ph.: krzysztof.szlichcinski@pekao.com.pl 27 October November 2016 Start of Blackout Period Third Quarter Report and Webcasting 35 Visit us at: Blackout Period two weeks period before publication of financial statements. During this period we do not organise meetings with investors and analysts

FINANCIAL RESULTS 1H 2016 Growth in key volumes and core revenues

FINANCIAL RESULTS 1H 2016 Growth in key volumes and core revenues FINANCIAL RESULTS 1H 2016 Growth in key volumes and core revenues Warsaw, 03.08.2016 Disclaimer This presentation (the Presentation ) has been prepared by Bank Polska Kasa Opieki Spółka Akcyjna ( Bank

More information

FINANCIAL RESULTS 1H 2015 Core revenues supporting 2015 plan delivery

FINANCIAL RESULTS 1H 2015 Core revenues supporting 2015 plan delivery FINANCIAL RESULTS 1H 2015 Core revenues supporting 2015 plan delivery Warsaw, 04.08.2015 Disclaimer This presentation (the Presentation ) has been prepared by Bank Polska Kasa Opieki Spółka Akcyjna ( Bank

More information

BANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1-

BANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1- BANK HANDLOWY W WARSZAWIE S.A. 1Q 29 consolidated financial results -1- Macroeconomic situation in 1Q 29 Deep drop in industrial output in January and February, albeit business confidence indicators suggest

More information

May 6, 2008 First Quarter 2008 Results

May 6, 2008 First Quarter 2008 Results SWEUB2227319CMDV7 May 6, 28 First Quarter 28 Results 1Q 28: Improved results in a challenging environment Page 2 Strong loan growth at 34.2% yoy Accelerated deposit growth at 31% yoy; improved loans /

More information

Growth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts

Growth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts Growth in core businesses offsets weaker non-interest income April 29, 2005 DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts This presentation is available at www.dbs.com/investor

More information

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes 1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements

More information

ARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK. Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011

ARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK. Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011 ARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011 STRUCTURE 1. National economy 2. International economy 3. Outlook 2 CENTRALE

More information

Endesa 1Q 2017 Results 09/05/2017

Endesa 1Q 2017 Results 09/05/2017 Endesa 1Q 2017 Results 09/05/2017 1. Highlights and key financial figures 2. Endesa s performance in 1Q 2017 market context 3. Financial results 4. Final remarks 2 1. Highlights and key financial figures

More information

Telekom Austria Group Results for the 1st Quarter May 27, 2003

Telekom Austria Group Results for the 1st Quarter May 27, 2003 Telekom Austria Group Results for the 1st Quarter 2003 May 27, 2003 1 Cautionary Statement This presentation contains certain forward-looking statements. Actual results may differ materially from those

More information

Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011

Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011 Hyundai Motor Company 1 st Quarter 2011 Business Results April 28, 2011 Cautionary Statement with Respect to Forward-Looking Statements In the presentation that follows and in related comments by Hyundai

More information

Enel Américas 1Q 2018 results

Enel Américas 1Q 2018 results Enel Américas 1Q 2018 results 1Q 2018 results Highlights of the period EBITDA of 820 musd, an increase of 26% vs 1Q 2017 Generation EBITDA increased by 17% due to better prices in Argentina and consolidation

More information

Korean Airlines Q Results

Korean Airlines Q Results Korean Airlines 2010 2Q Results 2010. 8. 13 1 Disclaimer This presentation is for informational purposes only, contains preliminary financial and other information about Korean Air Lines Co., Ltd. and

More information

Summary of Results for the First Half of FY2015/3

Summary of Results for the First Half of FY2015/3 Summary of Results for the First Half of FY2015/3 November 10, 2014 Tokyu Corporation (9005) http://www.tokyu.co.jp/ Contents Ⅰ.Executive Summary 2 Ⅱ.Conditions in Each Business 5 Ⅲ.Details of Financial

More information

Q Investor Kit JANUARY-JUNE 2013

Q Investor Kit JANUARY-JUNE 2013 Q2 2013 Investor Kit JANUARY-JUNE 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)

More information

Q Investor Kit JANUARY-MARCH 2014

Q Investor Kit JANUARY-MARCH 2014 Q1 2014 Investor Kit JANUARY-MARCH 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco

More information

1Q2017 法人說明會 Jun. 9, 2017

1Q2017 法人說明會 Jun. 9, 2017 1Q2017 法人說明會 Jun. 9, 2017 FE group business Span over 10 major industries Own over 240 companies Established in 1937 9 public listed companies in Taiwan and HK Petrochemical & energy Polyester & synthetic

More information

DELICA D:5 ACTIVE GEAR 0

DELICA D:5 ACTIVE GEAR 0 DELICA D:5 ACTIVE GEAR 0 1 1. FY2017 1Q Results 2. FY2017 1Q Results by Region 3. FY2017 Forecast 4. Initiatives for the Future FY2017 1Q Results Summary (vs. FY2016 1Q) (Apr-Jun 2016) (Apr-Jun 2017) (billion

More information

Q Investor Kit JANUARY-MARCH 2013

Q Investor Kit JANUARY-MARCH 2013 Q1 2013 Investor Kit JANUARY-MARCH 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)

More information

CENTRALE. Monetary. compared. domestic. million.

CENTRALE. Monetary. compared. domestic. million. CENTRALE BANK VAN ARUBAA Statistical News Release Second Quarter 2012 Date: November 7, 2012 Monetary and financial developments Money and credit In the second quarterr of 2012, the money supply decreased

More information

NATIONAL BANK OF POLAND

NATIONAL BANK OF POLAND NATIONAL BANK OF POLAND RECENT TRENDS IN THE REAL ESTATE MARKET INTERNATIONAL CONFERENCE THE HOUSING PRICES IN ROMANIA - recent developments - Ph.D. Andrei RĂDULESCU Senior Economist Researcher, IWE, Romanian

More information

Brisa Concessão Rodoviária. 1Q 2017 Traffic Update

Brisa Concessão Rodoviária. 1Q 2017 Traffic Update Brisa Concessão Rodoviária 1Q 2017 Traffic Update 15 th May 2017 Disclaimer The information contained herein ( Information ) has been prepared by Brisa Concessão Rodoviária, S.A. ("BCR") and which, according

More information

Q Investor Kit JANUARY-JUNE 2014

Q Investor Kit JANUARY-JUNE 2014 Q2 2014 Investor Kit JANUARY-JUNE 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco

More information

Q Investor Kit January December 2014

Q Investor Kit January December 2014 Q4 2014 Investor Kit January December 2014 Highlights for Q4 Sales up for all product areas and operating profit from product areas up by 8% Scandinavian hoarding for snus prior to tax increase in January

More information

PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public

PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public Incorporation of BVI Business Companies under the BVI Business Companies Act, 2004 1. Introduction The following is a brief summary of the main

More information

Group financial results for the first quarter 2008

Group financial results for the first quarter 2008 Helmut Perlet, Member of the Board of Management Group financial results for the first quarter 2008 Journalists Conference Call May 9th, 2008 Group: robust earnings in stormy weather (EUR mn) Quarterly

More information

Welcome to LG Electronics

Welcome to LG Electronics Welcome to LG Electronics April 21, 2004 As a note, this presentation has been prepared based on internal audited figures and final figures may change due to the results of independent auditors review.

More information

Portfolio Strategy Group

Portfolio Strategy Group PSG's Weekly Chart Perspective Portfolio Strategy Group Report Date: Monday, September 27, 21 Daily Close UST 1 Year CMT 5 Year History 5. 4.5 4. 3.5 3. 2.5 2. US Recession Sep-5 Dec-5 Mar-6 Jun-6 Sep-6

More information

Portfolio Strategy Group

Portfolio Strategy Group PSG's Weekly Chart Perspective Portfolio Strategy Group Report Date: Monday, November 15, 21 Daily Close UST 1 Year CMT 5 Year History 5. 4.5 4. 3.5 3. 2.5 2. US Recession Nov-5 Feb-6 May-6 Aug-6 Nov-6

More information

Summary Statement of Financial Position (consolidated)

Summary Statement of Financial Position (consolidated) 2012. 5. 3. 1 Disclaimer This presentation is for informational purposes only, contains preliminary financial and other information about Korean Air Lines Co., Ltd. and is subject to updating, revision,

More information

Inflation projection of the National Bank of Poland based on the NECMOD model

Inflation projection of the National Bank of Poland based on the NECMOD model Warsaw, July 1 Inflation projection of the National Bank of Poland based on the NECMOD model Economic Institute THE JUNE AS COMPARED TO THE FEBRUARY Change in the projection scenario Re-estimation of the

More information

Q4 Report Webcast February 7, 2019 Presenters: Renée Aguiar-Lucander, CEO Fredrik Johansson, CFO

Q4 Report Webcast February 7, 2019 Presenters: Renée Aguiar-Lucander, CEO Fredrik Johansson, CFO Q4 Report 2018 Webcast February 7, 2019 Presenters: Renée Aguiar-Lucander, CEO Fredrik Johansson, CFO Disclaimer Important information This presentation has been prepared by Calliditas Therapeutics AB

More information

FY2007 Consolidated Financial Overview

FY2007 Consolidated Financial Overview FY2007 Consolidated Financial Overview CHUGAI PHARMACEUTICAL CO., LTD. Executive Vice President and CFO Ryuzo Kodama January 30/31, 2008 Forward-Looking Statements This presentation may include forward-looking

More information

1Q 2009 Results Presentation. 12 May 2009

1Q 2009 Results Presentation. 12 May 2009 1Q 2009 Results Presentation 12 May 2009 1 Broadcasting 2 MEDIASET 2009 1Q Total Audience TOTAL AUDIENCE (Jan-Mar) * Individuals Δ vs. 2008 +5.3% 15-64 years +5.6% 1Q TV CONSUMPTION (2000-2009) Average

More information

BancAnalysts Association of Boston Conference Presentation. November 3, 2017

BancAnalysts Association of Boston Conference Presentation. November 3, 2017 BancAnalysts Association of Boston Conference Presentation November 3, 2017 Disclaimer This presentation contains forward- looking statements within the meaning of the Private Securities Litigation Reform

More information

For personal use only

For personal use only Cochlear Limited Results for the half year ended 31 December 2011 (H1 F12) Chris Roberts, CEO Neville Mitchell, CFO Cochlear Overview Cochlear Limited (ASX:COH): global leader in implantable devices for

More information

HILLENBRAND INDUSTRIES INC

HILLENBRAND INDUSTRIES INC HILLENBRAND INDUSTRIES INC FORM 8-K (Unscheduled Material Events) Filed 2/17/2004 For Period Ending 2/13/2004 Address 700 STATE ROUTE 46 E BATESVILLE, Indiana 47006-8835 Telephone 812-934-7000 CIK 0000047518

More information

ESM Pricing Policy. Element of Pricing and Calculation of Interest Rate. 1. Base Rate

ESM Pricing Policy. Element of Pricing and Calculation of Interest Rate. 1. Base Rate ESM Pricing Policy Objective When granting stability support, the ESM shall aim to fully cover its financing and operating costs and shall include an appropriate margin (Art. 20 of the Treaty). The main

More information

2010 First Quarter Results Presentation. 11 th May 2010

2010 First Quarter Results Presentation. 11 th May 2010 2010 First Quarter Results Presentation 11 th May 2010 1 Broadcasting 2 ITALY TV Consumption trend (2003-2010) Average Daily minutes 271 273 270 270 Individuals 269 266 255 250 251 245 251 256 245 244

More information

PVD (PVDrilling) Company Visit October 2011

PVD (PVDrilling) Company Visit October 2011 PVD (PVDrilling) Company Visit October 2011 2011 Preview: 3Q11 EBT margin is expected to be higher than 2Q11 largely due to no booking of provision for Science and Technology Development Fund According

More information

Brookings Institution, March 4, 2013 Laura Papi and IMF India Team

Brookings Institution, March 4, 2013 Laura Papi and IMF India Team Brookings Institution, March, 13 Laura Papi and IMF India Team The views expressed in this presentation are those of the authors and should not be attributed to the International Monetary Fund, its Executive

More information

FY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009

FY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009 FY2009 First Quarter Financial Results SUZUKI MOTOR CORPORATION August 3, 2009 Consolidated: Financial Summary Page 2 FY2009 1Q FY2008 4Q 09/4-6 09/1-3 Change FY2008 1Q 08/4-6 Change (Billion Yen) (A)

More information

Q2 INVESTOR KIT JANUARY-JUNE 2011

Q2 INVESTOR KIT JANUARY-JUNE 2011 Q2 INVESTOR KIT JANUARY-JUNE 2011 Swedish Match reporting segments Reporting segments following the transaction with STG on October 1, 2010 Snus and snuff - Swedish snus in Scandinavia and US - US moist

More information

Forward-Looking Statements

Forward-Looking Statements Investor Presentation May 2012 Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended.

More information

Results Presentation 2Q FY March Win-Partners Co., Ltd. (3183)

Results Presentation 2Q FY March Win-Partners Co., Ltd. (3183) Results Presentation 2Q FY March 2018 Win-Partners Co., Ltd. (3183) 2Q results ending September 2017 Consolidated results summary ( mil)2q to Sep 2016 Sep 2017 YoY OE Sales 27,713 29,753 +7.4% 29,500 Operating

More information

M e d i a s e t G r o u p

M e d i a s e t G r o u p M e d i a s e t G r o u p 11 th May 2004 2004 First Quarter Results M e d i a s e t G r o u p BROADCASTING MEDIASET 2004 1Q 24 Hours Audience Trend Individuals Share Points Vs 1Q 2003 OTHER SATELLITE 44.0%

More information

Third-quarter results 2013

Third-quarter results 2013 Third-quarter results 213 Fornebu, 6 November 213 Øyvind Eriksen and Leif Borge Agenda 213 Introduction Øyvind Eriksen Executive chairman Financials Leif Borge President & CFO Q&A Q&A session Øyvind Eriksen

More information

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf

More information

Small-Cap Research. VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive Data in Colon/Lung Cancers. Anticipating Initial Launch This Year OUTLOOK

Small-Cap Research. VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive Data in Colon/Lung Cancers. Anticipating Initial Launch This Year OUTLOOK Small-Cap Research February 2, 2016 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Ste 1600, Chicago, IL 60606 VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive

More information

Small-Cap Research. VolitionRx Ltd (VNRX-OTC) VNRX: 938-Sample Set Supports Earlier Findings of High Accuracy in Colon Cancer Detection OUTLOOK

Small-Cap Research. VolitionRx Ltd (VNRX-OTC) VNRX: 938-Sample Set Supports Earlier Findings of High Accuracy in Colon Cancer Detection OUTLOOK Small-Cap Research September 12, 2014 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Ste 1600, Chicago, IL 60606 VolitionRx Ltd (VNRX-OTC) VNRX: 938-Sample Set

More information

(City, State, Zip Code)

(City, State, Zip Code) This Partner Agency Agreement, dated this day of, 2015, is between COMMUNITY FOOD SHARE, INC. (CFS), whose address is 650 South Taylor Avenue, Louisville, CO 80027, and (Partner Agency) whose address is

More information

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology Company Update Industrial & Consumer Technology (XXII - $2.81 - Buy) COMPANY NOTE JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com Sales and trading 7 a.m. to 7 p.m. ET,

More information

Passion for progress, care for people

Passion for progress, care for people Passion for progress, care for people SPIL Analyst Meeting 25 th April, 2008 DISCLAIMER ACTUAL RESULTS / OUTCOMES MAY BE DIFFERENT FROM ANY FORWARD LOOKING STATEMENTS / VIEWS / ESTIMATES EXPRESSED HEREIN.

More information

RULES OF CONDUCT OF INSIDERS RESPECTING

RULES OF CONDUCT OF INSIDERS RESPECTING T RULES OF CONDUCT OF INSIDERS RESPECTING RADING O F SECURITIES OF TFI International lnc. Amended and restated July 2015 Executive Summary As an insider of TFI International Inc. ( TFI International )

More information

Results Presentation 2Q FY March Win-Partners Co., Ltd. (3183)

Results Presentation 2Q FY March Win-Partners Co., Ltd. (3183) Results Presentation 2Q FY March 2019 Win-Partners Co., Ltd. (3183) 2Q results ending September 2019 3 Consolidated results summary ( mil)2q to Sep 2017 Sep 2018 YoY OE Sales 29,753 31,863 +7.1% 31,700

More information

Operational Efficiency:

Operational Efficiency: Operational Efficiency: metrics that matter Copyright Altus Ltd 214. All rights reserved. Kevin Okell Consultancy Director 15/5/214 From distribution chain to value chain Ad-valorem pricing driven from

More information

Coloplast A/S. Investor presentation 1H 2005/06

Coloplast A/S. Investor presentation 1H 2005/06 Coloplast A/S Investor presentation 1H 2005/06 2 Coloplast Coloplast products and services help patients achieve greater independence from medical challenges in 4 areas: Ostomy care, continence care, wound

More information

Clovis Oncology Announces Q Operating Results and Corporate Update. November 3, :05 PM ET

Clovis Oncology Announces Q Operating Results and Corporate Update. November 3, :05 PM ET Clovis Oncology Announces Q3 2016 Operating Results and Corporate Update November 3, 2016 4:05 PM ET Rucaparib New Drug Application (NDA) accepted for Priority Review in the treatment of advanced BRCA-mutant

More information

Constitution for the National Association to Advance Fat Acceptance, Inc. PREAMBLE

Constitution for the National Association to Advance Fat Acceptance, Inc. PREAMBLE Constitution for the National Association to Advance Fat Acceptance, Inc. PREAMBLE The National Association to Advance Fat Acceptance is a nonprofit, member supported organization composed of determined

More information

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, András Tövisi Chairman of the Board of Directors

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, András Tövisi Chairman of the Board of Directors Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, 2014 András Tövisi Chairman of the Board of Directors Philip Morris ČR a.s. Annual General Meeting of Shareholders 2014

More information

Results Briefing Junichi Yoshii President & Representative Director

Results Briefing Junichi Yoshii President & Representative Director Fiscal Year Ending March 2010 Results Briefing Junichi Yoshii President & Representative Director May 14, 2010 1 Overview of Results (Consolidated) (Million yen) Net sales Operating profit Recurring income

More information

ELICA 2012 Q3 RESULTS. November 14,

ELICA 2012 Q3 RESULTS. November 14, ELICA ELICA 1 Q3 12 Highligths Negative market demand, showing better trend compared to previous quarters Group sales over performing in all major markets Cost reduction efforts and continued product innovation

More information

MARCH 2014 RESULTS PRESENTATION Madrid, 2014

MARCH 2014 RESULTS PRESENTATION Madrid, 2014 MARCH 2014 RESULTS PRESENTATION Madrid, 2014 Disclaimer In addition to figures prepared in accordance with IFRS, PRISA presents non-gaap financial performance measures, e.g., EBITDA, EBITDA margin, adjusted

More information

FIRSTQUARTER2018 RESULTSPRESENTATION

FIRSTQUARTER2018 RESULTSPRESENTATION FIRSTQUARTER2018 RESULTSPRESENTATION May 14 th 2018 Juan Lladó CEO 1 DISCLAIMER This document has been prepared by Técnicas Reunidas S.A. (the Company) solely for use at presentations held in connection

More information

Calliditas Therapeutics Q2 Report Webcast August 16, 2018, 10:00 Presenters: Renée Aguiar-Lucander, CEO Fredrik Johansson, CFO

Calliditas Therapeutics Q2 Report Webcast August 16, 2018, 10:00 Presenters: Renée Aguiar-Lucander, CEO Fredrik Johansson, CFO Calliditas Therapeutics Q2 Report 2018 Webcast August 16, 2018, 10:00 Presenters: Renée Aguiar-Lucander, CEO Fredrik Johansson, CFO Disclaimer Important information This presentation may contain certain

More information

Investor Presentation June 2012 NASDAQ: CEMI

Investor Presentation June 2012 NASDAQ: CEMI Investor Presentation June 2012 NASDAQ: CEMI Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act

More information

Consolidated: Financial Summary

Consolidated: Financial Summary FY2010 First Quarter Financial Results SUZUKI MOTOR CORPORATION 3 August 2010 Consolidated: Financial Summary Page2 FY2010 1Q FY2009 1Q (2010/4-6) (2009/4-6) Change Net sales 656.3 577.1 +79.2 +13.7% Operating

More information

1Q 2014 Earnings Release

1Q 2014 Earnings Release 1Q 2014 Earnings Release April 2014 DISCLAIMER Financial results for 1Q 2014 are provisional and accordingly subject to change according to the outside independent auditors review. This presentation contains

More information

artnet AG Quarterly Interim Statement for the First Quarter of 2016 artnet AG Quarterly Interim Statement for the First Quarter of 2016

artnet AG Quarterly Interim Statement for the First Quarter of 2016 artnet AG Quarterly Interim Statement for the First Quarter of 2016 Quarterly Interim Statement for the First Quarter of 2016 Quarterly Interim Statement for the First Quarter of 2016 for Table of Contents General Information and Business Activities Economic Development

More information

SUMMARY TERM SHEET. Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL )

SUMMARY TERM SHEET. Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL ) SUMMARY TERM SHEET Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL ) 2. Date of resolution May 28, 2014 passed by the Board of Directors authorizing the

More information

THIRD QUARTER REPORT 2011 (UNAUDITED)

THIRD QUARTER REPORT 2011 (UNAUDITED) THIRD QUARTER REPORT 2011 (UNAUDITED) Kronprinsesse Märthas pl. 1, Vika, 0166 Oslo, Norway. Tel: + 47 23 01 09 60, www.bionorpharma.com Page 1 THIRD QUARTER REPORT 2011 HIGHLIGHTS On the 25th August Bionor

More information

SWEDISH MATCH RESULTS PRESENTATION Q3 2017

SWEDISH MATCH RESULTS PRESENTATION Q3 2017 SWEDISH MATCH RESULTS PRESENTATION Q3 2017 DISCLAIMER The information contained in this presentation has not been independently verified and is subject to change without notice and neither Swedish Match,

More information

These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017.

These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017. Rules of Membership 1. Introduction These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017. The previously published

More information

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A Slide 1 Financial update and closing remarks Jesper Brandgaard EVP and CFO RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A Slide 2 Forward-looking statements Novo Nordisk s reports filed with or

More information

Q Investor Kit January December 2015

Q Investor Kit January December 2015 Q4 2015 Investor Kit January December 2015 Summary and Overview 2 Q4 and full year 2015: Headline numbers Sales for the full year increased by 9 percent and for the fourth quarter by 5 percent. In local

More information

Small-Cap Research. Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final Guidance for Phase 3 Protocol for TSC in Inoperable GBM OUTLOOK

Small-Cap Research. Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final Guidance for Phase 3 Protocol for TSC in Inoperable GBM OUTLOOK Small-Cap Research November 16, 2017 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final

More information

DRAFT FOR PUBLIC COMMENT Guidance Note for ESS9 Financial Intermediaries

DRAFT FOR PUBLIC COMMENT Guidance Note for ESS9 Financial Intermediaries The Guidance Notes provide guidance for the Borrower on the application of the Environmental and Social Standards (ESSs), which form part of the World Bank s 2016 Environmental and Social Framework. The

More information

artnet AG Quarterly Interim Statement for the First Quarter of 2017 artnet AG Quarterly Interim Statement for the First Quarter of 2017

artnet AG Quarterly Interim Statement for the First Quarter of 2017 artnet AG Quarterly Interim Statement for the First Quarter of 2017 Quarterly Interim Statement for the First Quarter of 2017 Quarterly Interim Statement for the First Quarter of 2017 Table of Contents General Information and Business Activities Economic Development of

More information

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018 CPH Chemie + Papier Holding AG Investor Day Perlen, 13 th September 2018 Agenda 2.00 pm Welcome 2.05 pm Presentation Course of Business 2018 2.50 pm Break 3.00 pm Presentation Perlen Packaging 3.30 pm

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 29, 2018 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Opiant Pharmaceuticals,

More information

22nd Century Group, Inc. (XXII - $ Buy) Q1 Far Ahead of Expectations

22nd Century Group, Inc. (XXII - $ Buy) Q1 Far Ahead of Expectations Company Update Industrial & Consumer Technology 22nd Century Group, Inc. (XXII - $2.21 - Buy) COMPANY NOTE Estimate Change JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com

More information

Presentation of. Burgdorf, 1 st November 2012

Presentation of. Burgdorf, 1 st November 2012 Presentation of Semi-Annual Results 2012/13 Burgdorf, 1 st November 2012 Important Notice The information contained in this document has not been independently verified and no representation or warranty,

More information

For personal use only

For personal use only HY18 Result Presentation 13 February 2018 Dig Howitt Brent Cubis CEO & President CFO HY18 Result highlights Strong momentum across developed markets continues Developed market unit growth up 12% Strengthening

More information

Investor Presentation

Investor Presentation ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an

More information

Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO

Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO Forward-looking statements The forward-looking statements contained in this presentation,

More information

Slide 1. Investor presentation. London 5 February 2019

Slide 1. Investor presentation. London 5 February 2019 Slide Investor presentation London 5 February 209 Slide 2 Forward-looking statements Novo Nordisk s reports filed with or furnished to the US Securities and Exchange Commission (SEC), including this presentation

More information

January 30, 2018 Dow Wilson President and Chief Executive Officer

January 30, 2018 Dow Wilson President and Chief Executive Officer Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking

More information

GLOBAL OUTLOOK ECONOMIC WATCH. March 2018

GLOBAL OUTLOOK ECONOMIC WATCH. March 2018 GLOBAL OUTLOOK ECONOMIC WATCH March 20 Global Outlook March 20 Strong global momentum continues in 1Q driven by trade, despite some weaker data in DM at the beginning of the year World GDP growth in 1Q

More information

Price List for Legal Entities of ProCredit Bank (Bulgaria) EAD

Price List for Legal Entities of ProCredit Bank (Bulgaria) EAD Price List for Legal Entities of ProCredit Bank (Bulgaria) EAD CONTENTS ACCOUNTS 3 TRANSFERS 4 CARDS 5 DOCUMENTARY 7 8 11 12 ACCOUNTS Current account Minimum balance BGN 250 Monthly maintenance fee, which

More information

INVESTOR PRESENTATION

INVESTOR PRESENTATION INVESTOR PRESENTATION JUNE 2016 OTCQB:CANN ABOUT General Cannabis Corporation (GCC) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We

More information

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical For immediate release November 25, 2004 Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical Sumitomo Chemical Co., Ltd. announced today that its subsidiary, Sumitomo

More information

Fully Employed MBA (MGMT FE)

Fully Employed MBA (MGMT FE) Fully Employed MBA (MGMT FE) 1 Fully Employed MBA (MGMT FE) Courses MGMT FE 200. Responding to Dynamic Times: Thinking Strategically in Organizations. 6 Units. Focuses on the strategic and organizational

More information

Singapore Exchange Limited 1Q FY2009 Financial Results

Singapore Exchange Limited 1Q FY2009 Financial Results Singapore Exchange Limited 1Q FY2009 Financial Results 15 October 2008 Singapore Exchange 1 1Q FY2009 Financial Performance NPAT fell 35% from record 1Q FY2008 Operating profit flat compared to 4Q FY2008

More information

Small-Cap Research. Celator Pharma (CPXX-NASDAQ)

Small-Cap Research. Celator Pharma (CPXX-NASDAQ) Small-Cap Research June 24, 2015 Grant Zeng, CFA 312-265-9466 gzeng@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Celator Pharma (CPXX-NASDAQ) CPXX: Positive top line data reported for

More information

Woongjin Coway. 1Q 12 IR Presentation

Woongjin Coway. 1Q 12 IR Presentation Woongjin Coway 1Q 12 IR Presentation Disclaimer This presentation contains historical information of the company which should not be regarded as an indication of the future performance or results. This

More information

Company overview. Highlights for the 1 st quarter 2018 (January-March)

Company overview. Highlights for the 1 st quarter 2018 (January-March) Company overview Vaccibody is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies. The company is a leader in the rapidly developing field of

More information

Telekom Austria Group Results for the First Quarter May 16, 2007

Telekom Austria Group Results for the First Quarter May 16, 2007 Telekom Austria Group Results for the First Quarter 2007 May 16, 2007 1 Cautionary Statement This presentation contains certain forward-looking statements. Actual results may differ materially from those

More information

FORM8-K HILLENBRAND,INC.

FORM8-K HILLENBRAND,INC. UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM8-K CURRENTREPORT PursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934 Date of Report (Date of earliest event reported): December18,2015

More information

Development Bank of Southern Africa Amendment Bill [B ]

Development Bank of Southern Africa Amendment Bill [B ] Development Bank of Southern Africa Amendment Bill [B 2-2014] Briefing of Select Committee on Finance National Council of Provinces 21 October 2014 Presenters : Mr Ben Mokheseng Deputy Director: Asset

More information

FY2016 1H Results. Cookpad Inc.

FY2016 1H Results. Cookpad Inc. FY2016 1H Results Cookpad Inc. 1 1H Highlights Premium Service -Premium Service revenue increased by 39.6% YoY. -Number of premium members grew by 12.0% YoY to exceed 1.85 million. Advertising -Advertising

More information

Fourth Quarter 2017 NCREIF Indices Review February 9, 2018

Fourth Quarter 2017 NCREIF Indices Review February 9, 2018 Fourth Quarter 2017 NCREIF Indices Review February 9, 2018 Panelist Overview Jeff Fisher NCREIF Data & Research Consultant Doug Herzbrun Global Head of Research CBRE Global Investors Disclaimer Today we

More information